Physician profile
John C Boys
NPI 1386645240
$913.37
in general payments reported to CMS, 2019-2025
13 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $11.34 · 2021: $125 · 2022: $216 · 2023: $14.70 · 2024: $180 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $337.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $211.10 | 2024-2025 | Aria Radiation Therapy Management Software |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.82 | 2019-2024 | Lifevest |
| Novo Nordisk INC | $125.00 | 2021 | |
| Mdd US Operations, LLC | $85.08 | 2019 | |
| Ucb, INC. | $75.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.00 | 2022 | |
| Abbvie INC. | $65.75 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $34.64 | 2025 | Farxiga |
| Kiniksa Pharmaceuticals International, Plc | $17.89 | 2024 | Arcalyst |
| Abbott Laboratories | $17.66 | 2024 | Accent |
| Merck Sharp & Dohme LLC | $15.37 | 2024 | Verquvo |
| Janssen Pharmaceuticals, INC | $15.36 | 2024 | Xarelto |
| Scpharmaceuticals INC. | $14.70 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Boys listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.